CHEMREGEN, INC.

Basic Information

11171 CORTE CANGREJO
SAN DIEGO, CA, 92130-2637

Company Profile

n/a

Additional Details

Field Value
DUNS: 831483388
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Small Molecule Therapeutics for Pancreatic Cancer

    Amount: $240,555.00

    Project Summary/Abstract Developing new ways to treat pancreatic cancer is a significant challenge. Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and res ...

    STTR Phase I 2014 Department of Health and Human Services
  2. Novel Medicinal Chemicals: Cardiomyogenesis from Human Stem Cells

    Amount: $172,538.00

    DESCRIPTION (provided by applicant): Over 1-2% of Americans greater than 65 years of age have heart disease. According to the American Heart Association, heart failure is one of the most common causes ...

    STTR Phase I 2011 Department of Health and Human Services
  3. Small Molecule Toolbox: Cardiomyocytes from Human Stem Cells

    Amount: $172,057.00

    DESCRIPTION (provided by applicant): It is estimated that more than 5 million Americans suffer from heart failure. The economic cost to US society for heart disease was almost 40 billion per in the y ...

    STTR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government